Newsroom

Sorted by: Latest

-

Tikehau Capital: Disclosure of Shares Repurchases from 09 January 2026 to 15 January 2026

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital (Paris:TKO): https://www.tikehaucapital.com/fr/shareholders/regulatory-information Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price per day Market (MIC Code) TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 01/09/2026 FR0013230612 2 03...
-

Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 09 janvier 2026 au 15 janvier 2026

PARIS--(BUSINESS WIRE)--Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital: (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen jo...
-

CRH plc UK Regulatory Announcement: Transaction in Own Shares

NEW YORK--(BUSINESS WIRE)--  16th January 2026 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 15th January 2026 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Santander US Capital Markets LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest price...
-

OrsoBio Announces Nature Medicine Publication Establishing Clinical and Mechanistic Validation of First-in-Class LXR Inverse Agonist TLC-2716 for the Treatment of Serious Metabolic Diseases

MENLO PARK, Calif.--(BUSINESS WIRE)--Preclinical and Phase 1 study published in Nature Medicine describes clinical and mechanistic validation for OrsoBio's LXR inverse agonist, TLC-2716....
-

U.K. Enterprises Redefine Multicloud Strategies

LONDON--(BUSINESS WIRE)--U.K. enterprises are adopting AI-native multicloud environments for agility, compliance and cost transparency amid tighter regulations, ISG says....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 15.01.2026 FEXD.LN IE00BWTNMB87 458,337.00 USD 41,754,939.52 91.101  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 15.01.2026 FEX.LN IE00B8X9NW27 1,032,271.00 USD 105,715,412.21 102.411  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 15.01.2026 CHPS.LN IE000KXTLDE2 500,002.00 USD 16,847,970.92 33.696  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 15.01.2026 MISL.LN IE000NVDQXE1 3,075,002.00 USD 113,747,320.11 36.991  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 15.01.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 10,354,747.00 23.010  ...